0.0750CAD0.00%Mkt Cap: 31.86M CADP/E: —Last update: 2026-06-01
MediPharm Labs Corp. operates as a pharmaceutical company that produces and sells purified, pharmaceutical-like cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Cana…
Industry Peers
Drug Manufacturers - Specialty & Generic150.78BSEKP/E 166.4
58.93BTRY—
56.89BEURP/E 22.4
32.78BPLNP/E 21.4
23.20BUSDP/E 20.2
18.39BUSD—
16.21BUSDP/E 24.8
13.00BTRY—
Indicators:|
Key Statistics
Company
Market Cap31.86M CAD
Enterprise Value22.02M CAD
Revenue (TTM)43.28M CAD
Gross Profit13.97M CAD
Net Income (TTM)-8.27M CAD
Revenue/Share0.1030 CAD
Last Price0.0750 CAD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees127
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINCA58504D1006
Valuation
P/E (Trailing)—
P/E (Forward)-7.50
PEG—
EV/EBITDA-3.60
EV/Revenue0.51
P/S0.74
P/B0.90
EPS (TTM)-0.02
EPS (Forward)-0.01
52W Range
0.060038% of range0.1000
52W High0.1000 CAD
52W Low0.0600 CAD
Profitability
Gross Margin30.95%
Oper. Margin-10.17%
EBITDA Margin-14.11%
Profit Margin-18.32%
ROE-23.08%
ROA-18.07%
Growth
Revenue Growth-17.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-5.50M CAD
CapEx (TTM)100.00K CAD
FCF Margin11.28%
FCF Yield15.32%
Net Debt-9.85M CAD
Net Debt/EBITDA1.61
Balance Sheet
Debt/Equity0.01
Current Ratio3.02
Quick Ratio1.93
Book Value/Sh0.0830 CAD
Cash/Share0.0230 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.424.86M
Float385.94M
Insiders11.31%
Institutions0.00%
Short Interest
Short Ratio0.5d
Short % Out.0.06%
Shares Short197.83K
Short (prev mo.)212.35K
Technical
SMA 500.0742 (+1.1%)
SMA 2000.0716 (+4.7%)
Beta—
S&P 52W Chg27.70%
Avg Vol (30d)446.18K
Avg Vol (10d)217.34K
Technical Indicators
RSI (14)42.8
MACD0.0004
MACD Signal0.0020
MACD Hist.-0.0016
BB Upper0.0916 CAD
BB Middle0.0828 CAD
BB Lower0.0739 CAD
BB Width21.44%
ATR (14)0.0052 CAD
Vol Ratio (20d)2.06x